chevron_leftBack
As of 6 June 2026, Imagion Biosystems Ltd. has a market cap of $5.95M USD, ranking #43742 globally and #1509 in Australia.
It ranks #3880 in the Healthcare sector, and #818 in the Medical Devices industry.
Key Stats
Market Cap
$5.95MUSD
8.34M AUD
Enterprise Value
$6.55MUSD
9.18M AUD
Revenue (TTM)
$52.12KUSD
73.03K AUD
EBITDA (TTM)
-$2.5MUSD
-3.5M AUD
Net Income (TTM)
-$3.08MUSD
-4.31M AUD
PS Ratio
114.2
PB Ratio
-3.9
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
Founded
2016
Website
imagionbiosystems.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -18% | -19% | -19% | -32% | -35% | 31% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
IBX
Imagion Biosystems Ltd
ISIN: AU000000IBX6
Shares Out.:
Shares Outstanding:
490.59M1
Shares Float:
490.407M2
|
0.0140 AUD | |
|
IBXXF
Imagion Biosystems Ltd
ISIN: AU000000IBX6
Shares Out.:
Shares Outstanding:
246.341M1
Shares Float:
246.109M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
0.0150 USD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Imagion Biosystems Ltd.
Imagion Biosystems Limited operates as a medical imaging company that uses bio-safe magnetic nanoparticles to detect cancer and other diseases in Australia. The company is involved in nanotechnology; biotechnology; medical imaging using magnetic resonance; and cancer diagnostics businesses. It develops MagSense, which is in Phase 2 for the treatment of HER2 breast cancers, as well as advancing the research and development programs for prostate and ovarian cancer. It also develops PrecisionMRX, an iron oxide nanoparticle to magnetic relaxometry. The company has collaboration agreement with Wayne State University to develop optimised MRI sequences which is in Phase 2 study of for the MagSense imaging agent. Imagion Biosystems Limited was incorporated in 2016 and is based in Melbourne, Australia.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
ASX: COH
|
$4.2B
70K%
5.89B AUD
|
17.1
|
|
NZE: EBO
|
$2.55B
43K%
4.34B NZD
|
16.0
|
|
ASX: CU6
|
$786.34M
13K%
1.1B AUD
|
-
|
|
ASX: NAN
|
$743.12M
12K%
1.04B AUD
|
52.3
|
|
ASX: TTX
|
$171.0M
3K%
239.61M AUD
|
-
|
|
ASX: OCC
|
$170.38M
3K%
238.75M AUD
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: TMO
|
$173.27B
3M%
|
25.8
|
|
NASDAQ: ISRG
|
$160.73B
3M%
|
56.7
|
|
NYSE: ABT
|
$159.07B
3M%
|
25.6
|
|
NYSE: DHR
|
$126.55B
2M%
|
34.7
|
|
NYSE: SYK
|
$120.69B
2M%
|
38.3
|
|
NYSE: MDT
|
$101.9B
2M%
|
22.2
|
chevron_leftBack